GCC Wound Closure Devices Market to Reach USD 778 Million by 2032, Growing at a CAGR of 4.93% During 2026–2032

The GCC wound closure devices market, valued at USD 551 Million in 2025, is projected to reach USD 778 Million by 2032, expanding at a CAGR of 4.93% during the forecast period of 2026–2032. This growth is underpinned by a structural expansion of surgical infrastructure across the six GCC states, driven by sustained government investment in hospital capacity, a sharp rise in chronic disease burden requiring operative intervention, and the progressive rollout of mandatory health insurance coverage that is bringing previously uninsured populations into formal surgical care pathways.

Saudi Arabia accounts for approximately 39% of regional market demand, anchored by the Kingdom’s Health Sector Transformation Program under Vision 2030. The Saudi government is committed to opening five new hospitals in 2025, adding 963 beds across Rijal Almaa, Dhahran Al-Janoub, Hail, Makkah, and Riyadh. Additionally, the Kingdom requires an estimated 27,000 additional beds by 2030 to meet projected surgical demand, with each bed representing direct expansion in suture and wound closure consumables procurement.

Furthermore, the UAE is accelerating demand through insurance-driven access reform. Effective January 1, 2025, the UAE Cabinet extended mandatory health insurance to private-sector employees and domestic workers across all seven emirates, including the five Northern Emirates previously excluded from coverage. Healthcare spending in the UAE is projected to reach USD 34 billion by 2027, with public sector expenditure growing at a CAGR of 7.5% and private sector spending at 8.8%, creating a measurable uplift in suture and wound closure device consumption.

Consequently, the rising adoption of advanced wound closure technologies is reshaping procurement preferences across GCC hospitals. In June 2025, Johnson & Johnson launched the ETHICON™ 4000 Stapler with proprietary 3D Staple Technology, while Medtronic launched the Signia™ Circular Stapler with Tri-Staple™ technology in November 2025, with the Middle East explicitly listed as a target market. As GCC hospitals continue scaling surgical capacity and transitioning toward minimally invasive techniques, demand for specialised wound closure consumables will accelerate in coming years, as stated in the recent report “GCC Wound Closure Devices Market Analysis, 2026”.

GCC Wound Closure Devices Market Highlights

The GCC Wound Closure Devices market, valued at USD 551 Million in 2025, is projected to reach USD 778 Million by 2032, expanding at a CAGR of 4.93%.
Saudi Arabia dominates the regional landscape with approximately 39% market share, underpinned by Vision 2030 healthcare investments and the highest surgical procedure volumes in the GCC.
The market remains highly fragmented, with the top five companies collectively holding only 22% share, leaving significant room for mid-tier and regional players to compete.
General surgery accounts for 35% of application-based demand, reflecting its broad procedural scope and universal presence across every tier of the GCC hospital network.
Rising obesity and diabetes prevalence across GCC nations, particularly Saudi Arabia, is directly fueling bariatric, metabolic, and abdominal surgical volumes, sustaining long-term suture demand growth.

GCC Wound Closure Devices Market Segmentation

By Product

Surgical Staplers
Tissue Adhesives & Sealants
Wound Closure Strips
Surgical Clips
Surgical Sutures
- Absorbable Sutures
  - Polyglactin 910 Sutures (Vicryl Type)
  - Polyglycolic Acid (PGA) Sutures
  - Poliglecaprone 25 Sutures (Monocryl Type)
  - Polydioxanone (PDO/PDS) Sutures
  - Catgut Sutures (Plain Catgut, Chromic Catgut)
- Non-Absorbable Sutures
  - Silk Sutures
  - Nylon Sutures
  - Polypropylene Sutures (Prolene Type)
  - Polyester Sutures
  - Stainless Steel Sutures
Others